West Pharmaceutical Services Inc SEC filings WST
West Pharmaceutical Services Inc has 1,001 filings in SEC EDGAR's recent list, going back to Aug 14, 2014. Its latest annual report, Form 10-K, was filed on Feb 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Mar 12, 2026 | — |
| DEF 14A | Proxy statement | Mar 12, 2026 | May 4, 2026 |
| DEFA14A | Additional proxy material | Mar 21, 2025 | — |
| DEF 14A | Proxy statement | Mar 21, 2025 | May 6, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 11, 2025 | May 6, 2025 |
| DEFA14A | Additional proxy material | Mar 13, 2024 | — |
| DEF 14A | Proxy statement | Mar 13, 2024 | Apr 23, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 1, 2024 | Apr 23, 2024 |
| DEFA14A | Additional proxy material | Mar 15, 2023 | — |
| DEF 14A | Proxy statement | Mar 15, 2023 | — |
| DEFA14A | Additional proxy material | Apr 14, 2022 | — |
| DEF 14A | Proxy statement | Apr 14, 2022 | May 14, 2022 |
| DEFA14A | Additional proxy material | Mar 24, 2021 | — |
| DEF 14A | Proxy statement | Mar 24, 2021 | May 4, 2021 |
| DEFA14A | Additional proxy material | Apr 17, 2020 | — |
| DEFA14A | Additional proxy material | Mar 25, 2020 | — |
| DEF 14A | Proxy statement | Mar 25, 2020 | May 5, 2020 |
| PRE 14A | Preliminary proxy statement | Mar 13, 2020 | May 5, 2020 |
| DEFA14A | Additional proxy material | Mar 22, 2019 | — |
| DEF 14A | Proxy statement | Mar 22, 2019 | May 7, 2019 |
| DEFA14A | Additional proxy material | Mar 21, 2018 | — |
| DEF 14A | Proxy statement | Mar 21, 2018 | May 1, 2018 |
| DEFA14A | Additional proxy material | Apr 14, 2017 | — |
| DEF 14A | Proxy statement | Mar 22, 2017 | May 2, 2017 |
| DEFA14A | Additional proxy material | Mar 16, 2017 | — |
| DEFA14A | Additional proxy material | Mar 24, 2016 | — |
| DEFA14A | Additional proxy material | Mar 23, 2016 | — |
| DEF 14A | Proxy statement | Mar 23, 2016 | May 3, 2016 |
| DEFA14A | Additional proxy material | Mar 24, 2015 | — |
| DEF 14A | Proxy statement | Mar 24, 2015 | May 5, 2015 |
| PRE 14A | Preliminary proxy statement | Mar 4, 2015 | May 5, 2015 |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- WST (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- PA
- Headquarters
- Exton, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 105770
- Former names
- WEST CO INC (until Feb 11, 1999)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.